SCHEMBL7002709

SCHEMBL7002709

Cc1cccc(C2C[C@H]2N)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.61
SLC6A3 Q01959 2/20 0.61
HTR2A P28223 1/20 0.61
SLC6A4 P31645 1/20 0.61
HTR2B P41595 1/20 0.61
KDM1A O60341 8/20 0.60
MAOB P27338 8/20 0.56
MAOA P21397 7/20 0.56
CYP2C19 P33261 4/20 0.56
CYP2B6 P20813 3/20 0.56
CYP2D6 P10635 3/20 0.56
CYP2C9 P11712 3/20 0.56
CYP1A2 P05177 2/20 0.56
LMNA P02545 2/20 0.56
TAAR1 Q96RJ0 2/20 0.56
CYP2A6 P11509 2/20 0.56
CYP3A4 P08684 1/20 0.56
HTR1A P08908 1/20 0.56
ADRA2A P08913 1/20 0.56
SLC6A2 P23975 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002711 1.00 HTR2C (0.61) HTR2CSLC6A3HTR2ASLC6A4HTR2B
SCHEMBL7092556 1.00 HTR2C (0.61) HTR2CSLC6A3HTR2ASLC6A4HTR2B
SCHEMBL12971953 0.84 KDM1A (0.51) HTR2CSLC6A3HTR2ASLC6A4HTR2B
SCHEMBL1645492 0.81 HTR2C (0.50) HTR2CSLC6A3HTR2ASLC6A4HTR2B
SCHEMBL1645493 0.81 HTR2C (0.50) HTR2CSLC6A3HTR2ASLC6A4HTR2B
SCHEMBL1646726 0.81 HTR2C (0.50) HTR2CSLC6A3HTR2ASLC6A4HTR2B
SCHEMBL7000209 0.78 KDM1A (0.48) HTR2CSLC6A3KDM1AMAOBMAOA
SCHEMBL7092952 0.78 KDM1A (0.48) HTR2CSLC6A3KDM1AMAOBMAOA
SCHEMBL7000211 0.78 KDM1A (0.48) HTR2CSLC6A3KDM1AMAOBMAOA
SCHEMBL14802698 0.77 HTR2C (0.97) HTR2CSLC6A3HTR2ASLC6A4HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed